| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SCMH1_0009400 | Exon-Exon | chr1:41578955-41627104 | chr1:41113283-41161432 | 1084 nt | 0.4696 |
| hsa_SCMH1_0009500 | Exon-Exon | chr1:41578955-41651922 | chr1:41113283-41186250 | 1071 nt | 0.4594 |
| hsa_SCMH1_0009600 | Exon-Intergenic | chr1:41578955-41707815 | chr1:41113283-41242143 | 1156 nt | 0.4827 |
| hsa_SCMH1_0011300 | Exon-Exon | chr1:41608550-41617356 | chr1:41142878-41151684 | 306 nt | 0.5033 |
| hsa_SCMH1_0011400 | Exon-Exon | chr1:41608550-41618413 | chr1:41142878-41152741 | 449 nt | 0.5011 |
| hsa_chr1_0871800 | Intergenic-Intergenic | chr1:41635298-41635636 | chr1:41169626-41169964 | 339 nt | 0.4808 |
| hsa_SCMH1_0013700 | Exon-Exon | chr1:41651793-41651922 | chr1:41186121-41186250 | 130 nt | 0.4154 |
| hsa_SCMH1_0013800 | Intron-Exon-Intron | chr1:41651793-41660071 | chr1:41186121-41194399 | 250 nt | 0.3040 |
| hsa_SCMH1_0015000 | Intron-Intron | chr1:41658051-41660071 | chr1:41192379-41194399 | 2021 nt | 0.3577 |
| hsa_CTPS1_0004500 | Exon-Intergenic | chr1:41471723-41494384 | chr1:41006051-41028712 | 44 nt | 0.5000 |
A study in humans demonstrated that the circSCMH1 is significantly decreased in the plasma of patients with acute ischemic stroke and is significant in predicting stroke outcomes [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in mice demonstrated that exosomes from adipose-derived stem cells delivering the circSCMH1 reduced nerve damage by promoting microglial M2 polarization [Li et al. DOI:10.1016/j.neuint.2023.105643].